PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-01-13

Date Title Company
13-Jan-2021 48Hour Discovery and Quantum Intelligence Corp Join Forces to Form Quantum Intelligence Discovery (QID) - An AI-Powered Drug Discovery Venture Businesswire
13-Jan-2021 Consumer Brief: Protecting Yourself from Defective Drug Risks During the Age of COVID-19 Businesswire
13-Jan-2021 BioPharma Services Pivots to Provide COVID-19 Testing for Entertainment Industry Businesswire
13-Jan-2021 Enrolment for AxisBiotix-Ps™ food supplement consumer study commences SkinBioTherapeutics plc
13-Jan-2021 Strategic Partnership Between Genedata and IDBS Aims to Further Streamline Biopharma Discovery, Development and Manufacturing Genedata and IDBS
13-Jan-2021 Synairgen announces commencement of dosing in its international Phase III study of inhaled interferon beta in hospitalised COVID-19 patients Synairgen plc
13-Jan-2021 Global Pegfilgrastim Biosimilars Market Opportunities and Strategies to 2030 - ResearchAndMarkets.com Businesswire
13-Jan-2021 Royal Free selects Induction to deliver new patient portal Induction Healthcare Group PLC
13-Jan-2021 Allergy Therapeutics plc Half Year Trading Update 2021 and Notice of Results Allergy Therapeutics plc
13-Jan-2021 Novo Seeds’ Portfolio Company, IO Biotech, Completes Oversubscribed EUR 127M Series B Financing to Accelerate Clinical Programs in Oncology Novo Seeds
13-Jan-2021 Global Language Services Market Insights & Forecast Report 2020-2024: Focus on Translation, Interpretation & Speech Recognition - ResearchAndMarkets.com Businesswire
13-Jan-2021 LIQUID BIOPSY: ONE-STOP-SHOP FOR IDENTIFYING CIRCULATING TUMOR CELLS USING PCR OR IMMUNOSTAINING OncoLab Diagnostics GmbH
13-Jan-2021 Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients with XSCID Businesswire
13-Jan-2021 Celltrion Group announces positive top-line efficacy and safety data from global Phase II/III clinical trial of COVID-19 treatment candidate CT-P59 Celltrion Group
13-Jan-2021 Ligand Receives Milestone Payment from Merck Businesswire
13-Jan-2021 Philogen Announces the Completion of a Second Interim Analysis of Its Phase III Clinical Program With Nidlegy for the Treatment of Melanoma Newswire
13-Jan-2021 Wipro Limited Announces Results for the Quarter ended December 31, 2020 under IFRS Businesswire
13-Jan-2021 SCHOTT’s Lebanon, Pa. Facility Reaches New Record in Glass Vial Production for COVID-19 Vaccine Businesswire
13-Jan-2021 Sesen Bio and Qilu Pharmaceutical Announce IND Application for Vicineum™ Accepted for Review by the National Medical Products Administration in China Businesswire
13-Jan-2021 New Research Data Across DXd ADC Portfolio at WCLC Showcases Daiichi Sankyo’s Continued Commitment in Lung Cancer Businesswire